Organovo is a regenerative medicine company focused on delivering breakthrough human tissue printing technology and creating tissue on demand for research and surgical applications. The company's NovoGen three-dimensional printing technology is a platform that works across all tissue and cell types. Organovo is helping physicians and researchers fulfill the promise of regenerative medicine by overcoming critical problems in cardiovascular medicine, medical research, and transplant medicine. Organovo technology leads the way in solving complex medical problems with one overarching goal: to benefit the health and lives of our patients.